Document is current
Any future updates will be listed below
-
Authors
Ewers, Bettina https://orcid.org/0000-0001-9425-1764
Blond, Martin B.
Bruun, Jens M.
Vilsbøll, Tina
-
Funding
Funding for this research was provided by:
Beckett-Fonden (17-2-0957)
Axel Muusfeldts Fond (2017-856)
Novo Nordic Foundation as part of an internal grant at Steno Diabetes Center Copenhagen in the Capital Region of Denmark.
- License Information
-
More Information
Article History
Received: 2 November 2023
Revised: 14 June 2024
Accepted: 18 June 2024
First Online: 27 June 2024
Competing interests
: BE owns shares in Novo Nordisk A/S. MBB has received research grants from Novo Nordisk A/S. TV and JMB have served on scientific advisory panels, been part of speaker’s bureaus, and served as a consultant to and/or received research support from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Gilead, GSK, Mundipharma, MSD/Merck, Novo Nordisk, Sanofi, and Sun Pharmaceuticals.
